Sector portfolio · VC firm · United States
venBio Partners' Biotech portfolio
venBio Partners has backed 11 Biotech startups in rounds we track, $1.9B between them, shown by the stage each has reached. The best-funded is Akero Therapeutics.
Funding by segment
- Series B$1.5B7
- Series C and later$447M4
Where they are based
- United States9$1.7B
- Switzerland1$132M
- United Kingdom1$100M
United States
Switzerland
United KingdomFounded
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M1
- $50M to $250M8
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
9 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
- Switzerland1
- United Kingdom1
Startups by country, 3 countries in all.
Segment by segment
Series B
7 startups · $1.5B raised
Akero TherapeuticsAkero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.United States$502M- CTCidara TherapeuticsCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.United States$463M
PharvarisPharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.Switzerland$132M
Arrakis TherapeuticsArrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.United States$113M
NeuroGastrxA private biopharmaceutical company .United States$105M
VicebioVicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.United Kingdom$100M
Checkmate PharmaceuticalsCheckmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.United States$69M
Series C and later
4 startups · $447M raised
MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M
Aragon PharmaceuticalsAragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer.United States$122M- INImpel NeuroPharmaUnited States$107M
- SHSwift Health SystemsUnited States$45M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names venBio Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like venBio Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.